4
Changes in Ownership
Contineum Therapeutics, Inc. Filed Acc 0001437749-25-002429
Options or other derivatives
- CMO & Sr VP, Clinical Dev. acquired 110,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Huhn Stephen L. · CMO & Sr VP, Clinical Dev.
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-01-31 | Grant or award : show line 1 in the form Stock Option (right to buy) | +110,000 | 110,000 | D |
Loading xslF345X05/rdgdoc.xml…